Literature DB >> 27866341

The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control.

Vanessa Ribeiro Figliuolo1,2, Suzana Passos Chaves1,2, Luiz Eduardo Baggio Savio1,2, Maria Luiza Prates Thorstenberg1, Érika Machado Salles3, Christina Maeda Takiya1, Maria Regina D'Império-Lima3, Herbert Leonel de Matos Guedes1, Bartira Rossi-Bergmann1,2, Robson Coutinho-Silva4,5,6.   

Abstract

Leishmania amazonensis is the etiological agent of diffuse cutaneous leishmaniasis. The immunopathology of leishmaniasis caused by L. amazonensis infection is dependent on the pathogenic role of effector CD4+ T cells. Purinergic signalling has been implicated in resistance to infection by different intracellular parasites. In this study, we evaluated the role of the P2X7 receptor in modulating the immune response and susceptibility to infection by L. amazonensis. We found that P2X7-deficient mice are more susceptible to L. amazonensis infection than wild-type (WT) mice. P2X7 deletion resulted in increased lesion size and parasite load. Our histological analysis showed an increase in cell infiltration in infected footpads of P2X7-deficient mice. Analysis of the cytokine profile in footpad homogenates showed increased levels of IFN-γ and decreased TGF-β production in P2X7-deficient mice, suggesting an exaggerated pro-inflammatory response. In addition, we observed that CD4+ and CD8+ T cells from infected P2X7-deficient mice exhibit a higher proliferative capacity than infected WT mice. These data suggest that P2X7 receptor plays a key role in parasite control by regulating T effector cells and inflammation during L. amazonensis infection.

Entities:  

Keywords:  ATP; L. amazonensis; Macrophages; P2X7; T cells

Mesh:

Substances:

Year:  2016        PMID: 27866341      PMCID: PMC5432475          DOI: 10.1007/s11302-016-9544-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  43 in total

1.  Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes.

Authors:  Lanfen Chen; Celia F Brosnan
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

2.  Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.

Authors:  L Soong; C H Chang; J Sun; B J Longley; N H Ruddle; R A Flavell; D McMahon-Pratt
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

3.  Interleukin-10 from T cells, but not macrophages and granulocytes, is required for chronic disease in Leishmania mexicana infection.

Authors:  Laurence U Buxbaum
Journal:  Infect Immun       Date:  2015-01-20       Impact factor: 3.441

4.  Implication of purinergic P2X7 receptor in M. tuberculosis infection and host interaction mechanisms: a mouse model study.

Authors:  André A Santos; Valnês Rodrigues-Junior; Rafael F Zanin; Thiago J Borges; Cristina Bonorino; Robson Coutinho-Silva; Christina M Takyia; Diógenes S Santos; Maria M Campos; Fernanda B Morrone
Journal:  Immunobiology       Date:  2013-03-16       Impact factor: 3.144

5.  Modulation of P2X(7) purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination.

Authors:  Suzana Passos Chaves; Eduardo Caio Torres-Santos; Camila Marques; Vanessa Ribeiro Figliuolo; Pedro Muanis Persechini; Robson Coutinho-Silva; Bartira Rossi-Bergmann
Journal:  Microbes Infect       Date:  2009-05-09       Impact factor: 2.700

Review 6.  The role of the P2X₇ receptor in infectious diseases.

Authors:  Catherine M Miller; Nicola R Boulter; Stephen J Fuller; Alana M Zakrzewski; Michael P Lees; Bernadette M Saunders; James S Wiley; Nicholas C Smith
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

Review 7.  P2X7 on Mouse T Cells: One Channel, Many Functions.

Authors:  Björn Rissiek; Friedrich Haag; Olivier Boyer; Friedrich Koch-Nolte; Sahil Adriouch
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

8.  The role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas State, Brazil.

Authors:  Thaís Tibery Espir; Luanda de Paula Figueira; Maricleide de Farias Naiff; Allyson Guimarães da Costa; Marcelo Ramalho-Ortigão; Adriana Malheiro; Antonia Maria Ramos Franco
Journal:  J Immunol Res       Date:  2014-09-11       Impact factor: 4.818

9.  CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.

Authors:  Charles F Anderson; Mohammed Oukka; Vijay J Kuchroo; David Sacks
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

10.  Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.

Authors:  Eduardo P Amaral; Simone C M Ribeiro; Verônica R Lanes; Fabrício M Almeida; Marcelle R M de Andrade; Caio Cesar Barbosa Bomfim; Erika M Salles; Karina R Bortoluci; Robson Coutinho-Silva; Mario H Hirata; José M Alvarez; Elena B Lasunskaia; Maria Regina D'Império-Lima
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

View more
  15 in total

Review 1.  Inflammasomes and Leishmania: in good times or bad, in sickness or in health.

Authors:  Dario S Zamboni; David L Sacks
Journal:  Curr Opin Microbiol       Date:  2019-06-20       Impact factor: 7.934

Review 2.  Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?

Authors:  P A F Pacheco; L P Dantas; L G B Ferreira; Robson Xavier Faria
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

Review 3.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

4.  Intralesional uridine-5'-triphosphate (UTP) treatment induced resistance to Leishmania amazonensis infection by boosting Th1 immune responses and reactive oxygen species production.

Authors:  Camila Marques-da-Silva; Mariana M Chaves; Maria Luiza Thorstenberg; Vanessa R Figliuolo; Flávia S Vieira; Suzana P Chaves; José Roberto Meyer-Fernandes; Bartira Rossi-Bergmann; Luiz Eduardo Baggio Savio; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2018-04-21       Impact factor: 3.765

Review 5.  P2RX7 at the Host-Pathogen Interface of Infectious Diseases.

Authors:  Alexandra Y Soare; Tracey L Freeman; Alice K Min; Hagerah S Malik; Elizabeth O Osota; Talia H Swartz
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

6.  NOD-Like Receptor P3 Inflammasome Controls Protective Th1/Th17 Immunity against Pulmonary Paracoccidioidomycosis.

Authors:  Claudia Feriotti; Eliseu Frank de Araújo; Flavio Vieira Loures; Tania Alves da Costa; Nayane Alves de Lima Galdino; Dario Simões Zamboni; Vera Lucia Garcia Calich
Journal:  Front Immunol       Date:  2017-07-10       Impact factor: 7.561

Review 7.  The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Authors:  Luiz E B Savio; Paola de Andrade Mello; Cleide Gonçalves da Silva; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

Review 8.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

9.  Purinergic Cooperation Between P2Y2 and P2X7 Receptors Promote Cutaneous Leishmaniasis Control: Involvement of Pannexin-1 and Leukotrienes.

Authors:  Maria Luiza Thorstenberg; Marcos Vinícius Rangel Ferreira; Natália Amorim; Claudio Canetti; Fernanda B Morrone; José Carlos Alves Filho; Robson Coutinho-Silva
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

Review 10.  P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?

Authors:  Chris N J Young; Dariusz C Górecki
Journal:  Front Chem       Date:  2018-06-28       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.